Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Ja… Read more
Market Cap & Net Worth: Jade Biosciences, Inc. (JBIO)
Jade Biosciences, Inc. (NASDAQ:JBIO) has a market capitalization of $450.34 Million ($450.34 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20476 globally and #7433 in its home market, demonstrating a -3.19% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jade Biosciences, Inc.'s stock price $13.97 by its total outstanding shares 32235900 (32.24 Million).
Jade Biosciences, Inc. Market Cap History: 2025 to 2026
Jade Biosciences, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $497.40 Million to $450.34 Million (0.00% CAGR).
Jade Biosciences, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jade Biosciences, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of JBIO by Market Capitalization
Companies near Jade Biosciences, Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Jade Biosciences, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Jade Biosciences, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Jade Biosciences, Inc.'s market cap moved from $497.40 Million to $ 450.34 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $450.34 Million | -9.46% |
| 2025 | $497.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Jade Biosciences, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $450.34 Million USD |
| MoneyControl | $450.34 Million USD |
| MarketWatch | $450.34 Million USD |
| marketcap.company | $450.34 Million USD |
| Reuters | $450.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.